Jeffrey Cole
Directeur des opérations chez CADRENAL THERAPEUTICS, INC.
Fortune : - $ au 30/04/2024
Profil
Jeffrey S.
Cole is the founder of Espero Pharmaceuticals, Inc. He is currently the Chief Operating Officer at Cadrenal Therapeutics, Inc. since 2024.
Previously, he served as the Chief Financial Officer at Legacy Pharmaceuticals International GmbH from 2008 to 2010.
Mr. Cole completed his undergraduate degree at the University of Southern California and holds an MBA from the University of Michigan.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 02/04/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Postes actifs de Jeffrey Cole
| Sociétés | Poste | Début |
|---|---|---|
| CADRENAL THERAPEUTICS, INC. | Directeur des opérations | 08/02/2024 |
Anciens postes connus de Jeffrey Cole
| Sociétés | Poste | Fin |
|---|---|---|
Legacy Pharmaceuticals International GmbH
 Legacy Pharmaceuticals International GmbH Financial ConglomeratesFinance Part of Legacy Pharmaceuticals International LLC, Legacy Pharmaceuticals International GmbH is a Swiss investment company with an interest in pharmaceutical companies. The company is based in Birsfelden, Switzerland. | Directeur Financier/CFO | 01/08/2010 |
Espero Pharmaceuticals, Inc.
 Espero Pharmaceuticals, Inc. Medical DistributorsDistribution Services Espero Pharmaceuticals, Inc. is a pharmaceutical company that specializes in developing therapeutics for unmet needs in thrombosis and cardiac rhythm control. Espero Pharmaceuticals is based in Jacksonville, FL and has subsidiaries in the United States. The private company's portfolio includes tecarfarin, which is used for patients requiring anticoagulation, and a novel candidate for treating arrhythmias. The company was founded by Jeffrey S. Cole and Quang X. Pham. | Fondateur | - |
Formation de Jeffrey Cole
| University of Southern California | Undergraduate Degree |
| University of Michigan | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CADRENAL THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Legacy Pharmaceuticals International GmbH
Legacy Pharmaceuticals International GmbH Financial ConglomeratesFinance Part of Legacy Pharmaceuticals International LLC, Legacy Pharmaceuticals International GmbH is a Swiss investment company with an interest in pharmaceutical companies. The company is based in Birsfelden, Switzerland. | Finance |
Espero Pharmaceuticals, Inc.
Espero Pharmaceuticals, Inc. Medical DistributorsDistribution Services Espero Pharmaceuticals, Inc. is a pharmaceutical company that specializes in developing therapeutics for unmet needs in thrombosis and cardiac rhythm control. Espero Pharmaceuticals is based in Jacksonville, FL and has subsidiaries in the United States. The private company's portfolio includes tecarfarin, which is used for patients requiring anticoagulation, and a novel candidate for treating arrhythmias. The company was founded by Jeffrey S. Cole and Quang X. Pham. | Distribution Services |
